SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-035812
Filing Date
2022-12-19
Accepted
2022-12-19 06:09:16
Documents
15
Period of Report
2022-12-13
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38679
2 ex4-1.htm EX-4.1 9253
3 ex4-2.htm EX-4.2 9216
4 ex4-3.htm EX-4.3 8077
  Complete submission text file 0001493152-22-035812.txt   250199

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20221213.xsd EX-101.SCH 3245
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20221213_lab.xml EX-101.LAB 34916
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20221213_pre.xml EX-101.PRE 22801
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3643
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 221469549
SIC: 3841 Surgical & Medical Instruments & Apparatus